Aerovate Therapeutics, Inc. (AVTE) has a market capitalization of $77.68M and trades at $2.68. The 52-week range is 2.6296-884.975.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-3,193.30.
The stock has a beta of 0.95, operates in the Healthcare sector.
